Status:
RECRUITING
Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe
Lead Sponsor:
University of Michigan Rogel Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Prostate Cancer
Eligibility:
MALE
40-80 years
Brief Summary
In this project, we will integrate the Photoacoustic (PA) technology into a prostate biopsy procedure through a fine needle probe. The needle probe will be in the shape of a biopsy needle and compatib...
Detailed Description
14AUG2024- enrollment was increased to 50 subjects
Eligibility Criteria
Inclusion
- 1\) Planned prostate biopsy as part of routine clinical care
- 2\) \> 40 and \<80 years old
Exclusion
- 1\) Known history of bleeding disorders or
- 2\) Patients taking anticoagulants, no matter doses or washout time
- 3\) Known allergy to silicone material
- 4\) Unable to provide informed consent
- 5\) Either the surgeon or the patient do not think the patient will not be able to complete all parts of the study, the patient will be excluded
- 6\) Involved in other investigational studies.
Key Trial Info
Start Date :
October 16 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05965180
Start Date
October 16 2023
End Date
October 1 2026
Last Update
November 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan Rogel Cancer Center
Ann Arbor, Michigan, United States, 48109